ALPHA1 ANTITRYPSIN DEFICIENCY

Clinical trials for ALPHA1 ANTITRYPSIN DEFICIENCY explained in plain language.

Never miss a new study

Get alerted when new ALPHA1 ANTITRYPSIN DEFICIENCY trials appear

Sign up with your email to follow new studies for ALPHA1 ANTITRYPSIN DEFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

Weekly shot tested for rare lung disease

Disease control Completed

This study tested the safety of two different doses of a weekly injection for people with Alpha-1 Antitrypsin Deficiency, a genetic condition that can cause lung disease. Seventeen adults with moderate lung impairment received the injections under the skin for eight weeks. The ma…

Matched conditions: ALPHA1 ANTITRYPSIN DEFICIENCY

Phase: PHASE1, PHASE2 • Sponsor: Grifols Therapeutics LLC • Aim: Disease control

Last updated Mar 24, 2026 12:02 UTC

ALPHA1 ANTITRYPSIN DEFICIENCY

Get alerted when new ALPHA1 ANTITRYPSIN DEFICIENCY trials appear

Weekly shot tested for rare lung disease